Delivery Order SPE2DB24D2205-SPE2DB25FDTYF
Award Date
11/12/24
Potential Completion Date
11/13/24
Potential Value
$5.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for $1,891.59 and was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMOX-CLAV 875-125 MG TABLET 100S, a type of antibiotic medication, and has an ultimate completion date of March 25, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant $999,999,999...
This federal contract award is a $3,383.56 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of AMOX-CLAV 875-125 MG TABLET 100S, a pharmaceutical product, with a performance period through June 17, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $1,511.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4560843903 AMOX-CLAV 875-125 MG TABLET 20S, a generic pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is May 8, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,543.50 firm fixed-price delivery order is for the supply of 4565751440 AMOX-CLAV 500-125 MG TABLET 20S. The contract has a completion date of September 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,668.84 delivery order contract is for the procurement of AMOX-CLAV 875-125 MG TABLET 20S, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of May 12, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,060.03 firm fixed-price delivery order is for AMOX-CLAV 250-125 MG TABLET 30S, a generic pharmaceutical product. The award is not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,265.87 delivery order is for the supply of Amox-Clav 875-125 mg tablets, a prescription medication. The contract has a firm-fixed price and an ultimate completion date of December 15, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,863.65, is for the delivery of AMOX-CLAV 875-125 MG TABLET 20S, a type of antibiotic medication. The contract has a firm fixed price pricing type and a period of performance through February 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of AMOX-CLAV 875-125 MG TABLET 20S. The contract has a ceiling value of $7,526.60 and a completion date of April 25, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,088.28 firm fixed-price delivery order is for AMOX-CLAV ER 1,000-62.5 MG TAB UU 28S, a pharmaceutical product, and has a completion date of December 19, 2023. The award is not associated with a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...